Ms Marilou Barratt, LCSW-C in Myersville, MD - Social Worker

Ms Marilou Barratt, LCSW-C is a Social Worker - Clinical based in Myersville, Maryland. Ms Marilou Barratt is licensed to practice in Maryland (license number 04111) and her current practice location is 10060 Vista Ct, Myersville, Maryland. She can be reached at her office (for appointments etc.) via phone at (240) 818-8344.

NPI number for Ms Marilou Barratt is 1013089051 and her current mailing address is 10060 Vista Ct, Myersville, Maryland. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1013089051.

Contact Information

	Ms Marilou Barratt, LCSW-C
	10060 Vista Ct, Myersville, MD 21773-8138
	(240) 818-8344
	Not Available

Healthcare Provider's Profile

Full Name	Ms Marilou Barratt
Gender	Female
Speciality	Social Worker - Clinical
Location	10060 Vista Ct, Myersville, Maryland
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1013089051
Provider Enumeration Date: 11/14/2006
Last Update Date: 10/29/2012

Medical Identifiers

Medical identifiers for Ms Marilou Barratt such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1013089051	NPI	-	NPPES
010010391	Other	CA	INTEGRATED BEHAVIORAL HEA
QR55M	Other	MD	CAREFIRST BCBS OF MD
R5440001	Other	MD	CAREFIRST BCBS-FED EMPLOY
4223346	Other	MD	AETNA ID #
QR55	Other	MD	MAGELLAN
17707	Other	MD	CIGNA
181602YAZG	Other	MD	IND. PTAN
183417	Other	MD	INC PTAN
R5440001	Other	MD	CAREFIRST BLUE CHOICE
324025	Other	MD	MAMSI, ALLLIANCE, OPTIMUM
002258	Other	MI	VALUEOPTIONS
PVPB122176	Other	MD	AM PSYCH SERVICES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1041C0700X	Social Worker - Clinical	04111 (Maryland)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Ms Marilou Barratt is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Ms Marilou Barratt, LCSW-C 10060 Vista Ct, Myersville, MD 21773-8138 Ph: (240) 818-8344	Ms Marilou Barratt, LCSW-C 10060 Vista Ct, Myersville, MD 21773-8138 Ph: (240) 818-8344

News Archive

Vaporized cannabis increases drug-seeking behavior, study shows

Rats with regular access to cannabis seek more of the substance and tend to show increased drug-seeking behavior when cannabis is absent.

Federal judge passes consent order against Shamrock Medical for distributing mislabeled drugs

The U.S. Food and Drug Administration announced today that federal judge Algenon L. Marbley of the Southern District of Ohio has approved a consent decree of permanent injunction against Shamrock Medical Solutions Group, LLC, of Lewis Center, Ohio, and four of its corporate officers and employees for continued drug manufacturing and labeling violations that resulted in the distribution of mislabeled drugs.

New Allen Mouse Brain Connectivity Atlas

The Allen Institute for Brain Science announced today the launch of a new brain atlas resource and updates to four existing resources, all publicly available online to accelerate brain research around the globe.

VBL's VB-111 preclinical data against metastatic cancer to be presented at AACR meeting

VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.

CYP2C19 gene variant can increase risk of cardiovascular events in patients treated with clopidogrel

An analysis of data from previously published studies indicates that use of the antiplatelet drug clopidogrel for patients who have common genetic variants of a certain gene and are undergoing a procedure such as coronary stent placement have an associated increased risk for major adverse cardiovascular events, particularly development of blood clots in stents, according to a study in the October 27 issue of JAMA.

Ms Marilou Barratt, LCSW-C - Clinical Social Worker in Myersville, MD